* Angiotech Pharmaceuticals Inc., of Vancouver, Canada, appointed to its board of directors Jeremy Cumock Cook, managing director and team leader of the Rothschild Bioscience Unit, also of Vancouver.

* Aquila Biopharmaceuticals, of Worcester, Mass. named Robert Carpente rto its board of directors. ,Carpenter is president of Boston Medical Investors of Wellesley, Mass.

* Aradigm Corp., of Hayward, Calif. named Bikash Catterjee vice president of operations.

* ArQule Inc., of Medford, Mass appointed Michael Rosenblatt to its board of directors. Rosenblatt is an Ebert professor of molecular medicine at Harvard Medical School and senior vice president for academic affairs at Beth Israel Deaconess Medical Center,

* Biora AB, of Malmo, Sweden, named Anders Agering to the position of senior vice president and deputy CEO.

* Bio-Technology General Corp., of Iselin, N.J., named Robert Shaw vice president, general counsel.

* Celgene Corp., of Warren, N.J., elected Jack Bowman and Gila Kaplin to its board of directors. Bowman is former company group chairman of Johnson & Johnson of New Brunswick, N.J., and Kaplin is on the faculty at New York-based Rockefeller University in the Laboratory of Cellular Physiology and Immunology,

* ChemTrak Inc., of Sunnyvale, Calif., named Rene Cervantes vice president of operations and Frank Pettebone controller.

* Chiron Corp., of Emeryville, Calif., appointed Jacob Plattner vice president of small molecule discovery research.

* Clinicor Inc., of Austin, Texas, appointed Susan Krivacic senior vice president for marketing and business development.

* Coulter Pharmaceutical Inc., of Palo Alto, Calif., named Michael Spellman vice president for preclinical development.

* Cytel Corp., of San Diego, Calif., named Nancy Rasmussen to its board of directors. Rasmussen is vice president of global new business franchise of G.D. Searle & Co.

* Dade Behring Inc., of Deerfield, Ill, named David Edelstein chief information officer.

* Derma Sciences Inc., of Princeton, N.J., appointed Srini Conjeevaram to its board of directors. Conjeevaram is general partner and chief financial officer of Galen Associates, of New York.

* DiaDexus LLC, of Santa Clara, Calif., named William Gerber president and CEO.

* Endorex Corp., of Chicago, Ill., named Hansi Dean director for adjuvants and new vaccines.

* Epimmune Inc., of San Diego, Calif., named Peter Wulff vice president for finance.

* Everest Medical Corp., of Minneapolis, Minn., appointed David Parins to the position of vice president for technology.

* Forbes Medi-Tech Inc., of Vancouver, Canada, named George Steiner to its medical advisory board. Steiner is a professor of medicine and physiology at the University of Toronto and director of the Lipid Research Clinic at Toronto General Hospital,

* Genentech Inc., of South San Francisco, Calif., appointed Walter Moore head of the company's government affairs office.

* GeneTrace Systems Inc., of Menlo Park, Calif. named as CEO George LaMotte, and appointed Ronald FitzGerald senior director of operations.

* Gilead Sciences Inc., of Foster City, Calif., named Paul Berg to its board of directors. Berg is a Cahill professor in cancer research in the department of biochemistry at Stanford University School of Medicine.

* Hepatix Inc., of La Jolla, Calif., named Robert Johnson chief operating officer.

* Kosan Biosciences, of Burlingame, Calif., named Raymond Whitaker and Peter Davis to its board of directors. Whitaker is a vice president of S.R. One. Ltd, of Wayne, Pa., and Davis is a member of the executive committee of Pulsar Internacional, S.A., of West Conshohoken, Pa.

* Laboratory Corp., of Burlington, N.C., named Myla Lai-Goldman executive vice president, chief scientific officer and medical director.

* LXR Biotechnology, of Richmond Calif., named John Kane to its board of directors. Kane is president and chief operating officer of Cardinal Health Inc., of Dublin, Ohio.

* Maxim Pharmaceuticals, of San Diego, made three appointments: Geoffrey Altman, senior director for marketing and sales; F. David King, senior director for business development; and Dean Work, managing director for vaccines.

* MitoKor, of San Diego, named Thomas Sanders executive director for business and corporate development. The company also appointed to its Scientific Advisory Board Dale Bredesen of the Burnham Institute, in San Diego, Calif.

* NeoPharm Inc., of Bannockburn, Ill., added Lewis Strauss to its staff as vice president of medical affairs.

* Neurex Corp., of Menlo Park, Calif., appointed Sandy Cooper vice president human of resources.

* NeuroMetrix Inc., of Cambridge, Mass., named Richard Thomas president.

* Neurotech S.A., of Paris, named Tom Shepherd its chief executive office.

* Onyx Pharmaceuticals Inc., of Richmond, Calif., named Mary Ann Rafferty vice president of human resources.

* Sequus Pharmaceuticals Inc., of Menlo Park, Calif., promoted Michael Ramsay vice president of manufacturing operations.

* Shaman Pharmaceuticals Inc., of South San Francisco, Calif., named Jose Roberto Borges to its ethnobotany and conservation group.